Loading…
Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells
To evaluate the effect of galectin‐3 in cell cycle regulation of colon cancer cells, we looked for binding molecules interacting with galectin‐3 and examined the changes in cell cycle by suppressing galectin‐3 and the binding molecule. To identify target molecules interacting with galectin‐3, we ana...
Saved in:
Published in: | Cancer science 2008-10, Vol.99 (10), p.1884-1891 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1891 |
container_issue | 10 |
container_start_page | 1884 |
container_title | Cancer science |
container_volume | 99 |
creator | Kim, Duck‐Woo Kim, Kyung Hee Yoo, Byong Chul Hong, Sung‐Hye Lim, Yong Chul Shin, Young‐Kyoung Park, Jae‐Gahb |
description | To evaluate the effect of galectin‐3 in cell cycle regulation of colon cancer cells, we looked for binding molecules interacting with galectin‐3 and examined the changes in cell cycle by suppressing galectin‐3 and the binding molecule. To identify target molecules interacting with galectin‐3, we analyzed immunoprecipitate of the anti‐galectin‐3 antibody obtained from human colon cancer cell line, using matrix‐assisted laser desorption ionization‐mass spectrometry. We validated subcellular localization of galectin‐3 and ATP synthase identified, and ATP synthase activity was determined in the presence of galectin‐3. Cell cycle regulation was monitored after galectin‐3 siRNA transfection. ATP synthase b‐subunit was identified in immunoprecipitate of the anti‐galectin‐3 antibody. Galectin‐3 and ATP synthase were co‐isolated in the inner membrane vesicles of mitochondria. Galectin‐3 has an inhibitory activity against ATP synthase, and intracellular ATP content showed increasing tendency after galectin‐3 suppression. Suppression of galectin‐3 resulted in G0/G1 progression of human colon cancer cells arrested at S, S/G2 and G2/M phase in the presence of doxorubicin, and etoposide or nocodazole, respectively. Compared to cells in which ATP synthase d‐subunit was suppressed alone, sub‐G1 fraction caused by etoposide or nocodazole was decreased in cells with galectin‐3 suppression alone. In conclusion, galectin‐3 co‐localized with ATP synthase in the inner membrane of mitochondria and has an inhibitory effect on ATP synthase in human colon cancer cells. In the presence of cell cycle synchronizing drugs, doxorubicin, etoposide, or nocodazole, suppression of galectin‐3 induced cell cycle progression to G0/G1 phase. (Cancer Sci 2008; 99: 1884–1891) |
doi_str_mv | 10.1111/j.1349-7006.2008.00901.x |
format | article |
fullrecord | <record><control><sourceid>wiley_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11160105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CAS901</sourcerecordid><originalsourceid>FETCH-LOGICAL-j2981-3fef695547da26eedc0c5755fd715cd7242c0244cc5319c3bb13e93e0d2be4563</originalsourceid><addsrcrecordid>eNpVkd9KwzAUxoMobv55h9x42Xryr11AkDGcDgYKzuuQpumWkbWjrW678xF8Rp_EdBsDc3PO4fvyg3M-hDCBmIR3v4wJ4zJKAZKYAgxiAAkk3p6h_kk43_dpJIHRHrpqmiUAS7jkl6hHgjtJedJH80luy9YVzujWVSWuCrxybWUWVZnXTns8JmP4_f4Zzt5wsyvbhW4sdmVra21aV87xxrULPNfedmMwsqBiU_nAMro0tsbGet_coItC-8beHus1-hg_zUYv0fT1eTIaTqMllQMSscIWiRSCp7mmibW5ASNSIYo8JcLkKeXUAOXcGMGINCzLCLOSWchpZrlI2DV6PHDXn9kqfA_L1dqrde1Wut6pSjv1XyndQs2rLxXOmgABEQh3R4JujPZFHbZwzYlAYSA4EBl8Dwffxnm7O-kEOhRRS9UlobokVBeR2kektmo0fA8N-wNuB4iw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Kim, Duck‐Woo ; Kim, Kyung Hee ; Yoo, Byong Chul ; Hong, Sung‐Hye ; Lim, Yong Chul ; Shin, Young‐Kyoung ; Park, Jae‐Gahb</creator><creatorcontrib>Kim, Duck‐Woo ; Kim, Kyung Hee ; Yoo, Byong Chul ; Hong, Sung‐Hye ; Lim, Yong Chul ; Shin, Young‐Kyoung ; Park, Jae‐Gahb</creatorcontrib><description>To evaluate the effect of galectin‐3 in cell cycle regulation of colon cancer cells, we looked for binding molecules interacting with galectin‐3 and examined the changes in cell cycle by suppressing galectin‐3 and the binding molecule. To identify target molecules interacting with galectin‐3, we analyzed immunoprecipitate of the anti‐galectin‐3 antibody obtained from human colon cancer cell line, using matrix‐assisted laser desorption ionization‐mass spectrometry. We validated subcellular localization of galectin‐3 and ATP synthase identified, and ATP synthase activity was determined in the presence of galectin‐3. Cell cycle regulation was monitored after galectin‐3 siRNA transfection. ATP synthase b‐subunit was identified in immunoprecipitate of the anti‐galectin‐3 antibody. Galectin‐3 and ATP synthase were co‐isolated in the inner membrane vesicles of mitochondria. Galectin‐3 has an inhibitory activity against ATP synthase, and intracellular ATP content showed increasing tendency after galectin‐3 suppression. Suppression of galectin‐3 resulted in G0/G1 progression of human colon cancer cells arrested at S, S/G2 and G2/M phase in the presence of doxorubicin, and etoposide or nocodazole, respectively. Compared to cells in which ATP synthase d‐subunit was suppressed alone, sub‐G1 fraction caused by etoposide or nocodazole was decreased in cells with galectin‐3 suppression alone. In conclusion, galectin‐3 co‐localized with ATP synthase in the inner membrane of mitochondria and has an inhibitory effect on ATP synthase in human colon cancer cells. In the presence of cell cycle synchronizing drugs, doxorubicin, etoposide, or nocodazole, suppression of galectin‐3 induced cell cycle progression to G0/G1 phase. (Cancer Sci 2008; 99: 1884–1891)</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/j.1349-7006.2008.00901.x</identifier><identifier>PMID: 19016746</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Biological and medical sciences ; Gastroenterology. Liver. Pancreas. Abdomen ; Medical sciences ; Original ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Cancer science, 2008-10, Vol.99 (10), p.1884-1891</ispartof><rights>2008 Japanese Cancer Association</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160105/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160105/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,27924,27925,46052,46476,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1349-7006.2008.00901.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20854019$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Duck‐Woo</creatorcontrib><creatorcontrib>Kim, Kyung Hee</creatorcontrib><creatorcontrib>Yoo, Byong Chul</creatorcontrib><creatorcontrib>Hong, Sung‐Hye</creatorcontrib><creatorcontrib>Lim, Yong Chul</creatorcontrib><creatorcontrib>Shin, Young‐Kyoung</creatorcontrib><creatorcontrib>Park, Jae‐Gahb</creatorcontrib><title>Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells</title><title>Cancer science</title><description>To evaluate the effect of galectin‐3 in cell cycle regulation of colon cancer cells, we looked for binding molecules interacting with galectin‐3 and examined the changes in cell cycle by suppressing galectin‐3 and the binding molecule. To identify target molecules interacting with galectin‐3, we analyzed immunoprecipitate of the anti‐galectin‐3 antibody obtained from human colon cancer cell line, using matrix‐assisted laser desorption ionization‐mass spectrometry. We validated subcellular localization of galectin‐3 and ATP synthase identified, and ATP synthase activity was determined in the presence of galectin‐3. Cell cycle regulation was monitored after galectin‐3 siRNA transfection. ATP synthase b‐subunit was identified in immunoprecipitate of the anti‐galectin‐3 antibody. Galectin‐3 and ATP synthase were co‐isolated in the inner membrane vesicles of mitochondria. Galectin‐3 has an inhibitory activity against ATP synthase, and intracellular ATP content showed increasing tendency after galectin‐3 suppression. Suppression of galectin‐3 resulted in G0/G1 progression of human colon cancer cells arrested at S, S/G2 and G2/M phase in the presence of doxorubicin, and etoposide or nocodazole, respectively. Compared to cells in which ATP synthase d‐subunit was suppressed alone, sub‐G1 fraction caused by etoposide or nocodazole was decreased in cells with galectin‐3 suppression alone. In conclusion, galectin‐3 co‐localized with ATP synthase in the inner membrane of mitochondria and has an inhibitory effect on ATP synthase in human colon cancer cells. In the presence of cell cycle synchronizing drugs, doxorubicin, etoposide, or nocodazole, suppression of galectin‐3 induced cell cycle progression to G0/G1 phase. (Cancer Sci 2008; 99: 1884–1891)</description><subject>Biological and medical sciences</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Medical sciences</subject><subject>Original</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkd9KwzAUxoMobv55h9x42Xryr11AkDGcDgYKzuuQpumWkbWjrW678xF8Rp_EdBsDc3PO4fvyg3M-hDCBmIR3v4wJ4zJKAZKYAgxiAAkk3p6h_kk43_dpJIHRHrpqmiUAS7jkl6hHgjtJedJH80luy9YVzujWVSWuCrxybWUWVZnXTns8JmP4_f4Zzt5wsyvbhW4sdmVra21aV87xxrULPNfedmMwsqBiU_nAMro0tsbGet_coItC-8beHus1-hg_zUYv0fT1eTIaTqMllQMSscIWiRSCp7mmibW5ASNSIYo8JcLkKeXUAOXcGMGINCzLCLOSWchpZrlI2DV6PHDXn9kqfA_L1dqrde1Wut6pSjv1XyndQs2rLxXOmgABEQh3R4JujPZFHbZwzYlAYSA4EBl8Dwffxnm7O-kEOhRRS9UlobokVBeR2kektmo0fA8N-wNuB4iw</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Kim, Duck‐Woo</creator><creator>Kim, Kyung Hee</creator><creator>Yoo, Byong Chul</creator><creator>Hong, Sung‐Hye</creator><creator>Lim, Yong Chul</creator><creator>Shin, Young‐Kyoung</creator><creator>Park, Jae‐Gahb</creator><general>Blackwell Publishing Asia</general><general>Blackwell</general><scope>IQODW</scope><scope>5PM</scope></search><sort><creationdate>200810</creationdate><title>Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells</title><author>Kim, Duck‐Woo ; Kim, Kyung Hee ; Yoo, Byong Chul ; Hong, Sung‐Hye ; Lim, Yong Chul ; Shin, Young‐Kyoung ; Park, Jae‐Gahb</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j2981-3fef695547da26eedc0c5755fd715cd7242c0244cc5319c3bb13e93e0d2be4563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Medical sciences</topic><topic>Original</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Duck‐Woo</creatorcontrib><creatorcontrib>Kim, Kyung Hee</creatorcontrib><creatorcontrib>Yoo, Byong Chul</creatorcontrib><creatorcontrib>Hong, Sung‐Hye</creatorcontrib><creatorcontrib>Lim, Yong Chul</creatorcontrib><creatorcontrib>Shin, Young‐Kyoung</creatorcontrib><creatorcontrib>Park, Jae‐Gahb</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kim, Duck‐Woo</au><au>Kim, Kyung Hee</au><au>Yoo, Byong Chul</au><au>Hong, Sung‐Hye</au><au>Lim, Yong Chul</au><au>Shin, Young‐Kyoung</au><au>Park, Jae‐Gahb</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells</atitle><jtitle>Cancer science</jtitle><date>2008-10</date><risdate>2008</risdate><volume>99</volume><issue>10</issue><spage>1884</spage><epage>1891</epage><pages>1884-1891</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>To evaluate the effect of galectin‐3 in cell cycle regulation of colon cancer cells, we looked for binding molecules interacting with galectin‐3 and examined the changes in cell cycle by suppressing galectin‐3 and the binding molecule. To identify target molecules interacting with galectin‐3, we analyzed immunoprecipitate of the anti‐galectin‐3 antibody obtained from human colon cancer cell line, using matrix‐assisted laser desorption ionization‐mass spectrometry. We validated subcellular localization of galectin‐3 and ATP synthase identified, and ATP synthase activity was determined in the presence of galectin‐3. Cell cycle regulation was monitored after galectin‐3 siRNA transfection. ATP synthase b‐subunit was identified in immunoprecipitate of the anti‐galectin‐3 antibody. Galectin‐3 and ATP synthase were co‐isolated in the inner membrane vesicles of mitochondria. Galectin‐3 has an inhibitory activity against ATP synthase, and intracellular ATP content showed increasing tendency after galectin‐3 suppression. Suppression of galectin‐3 resulted in G0/G1 progression of human colon cancer cells arrested at S, S/G2 and G2/M phase in the presence of doxorubicin, and etoposide or nocodazole, respectively. Compared to cells in which ATP synthase d‐subunit was suppressed alone, sub‐G1 fraction caused by etoposide or nocodazole was decreased in cells with galectin‐3 suppression alone. In conclusion, galectin‐3 co‐localized with ATP synthase in the inner membrane of mitochondria and has an inhibitory effect on ATP synthase in human colon cancer cells. In the presence of cell cycle synchronizing drugs, doxorubicin, etoposide, or nocodazole, suppression of galectin‐3 induced cell cycle progression to G0/G1 phase. (Cancer Sci 2008; 99: 1884–1891)</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19016746</pmid><doi>10.1111/j.1349-7006.2008.00901.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1347-9032 |
ispartof | Cancer science, 2008-10, Vol.99 (10), p.1884-1891 |
issn | 1347-9032 1349-7006 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11160105 |
source | Open Access: Wiley-Blackwell Open Access Journals |
subjects | Biological and medical sciences Gastroenterology. Liver. Pancreas. Abdomen Medical sciences Original Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors |
title | Identification of mitochondrial F1F0‐ATP synthase interacting with galectin‐3 in colon cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20mitochondrial%20F1F0%E2%80%90ATP%20synthase%20interacting%20with%20galectin%E2%80%903%20in%20colon%20cancer%20cells&rft.jtitle=Cancer%20science&rft.au=Kim,%20Duck%E2%80%90Woo&rft.date=2008-10&rft.volume=99&rft.issue=10&rft.spage=1884&rft.epage=1891&rft.pages=1884-1891&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/j.1349-7006.2008.00901.x&rft_dat=%3Cwiley_24P%3ECAS901%3C/wiley_24P%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-j2981-3fef695547da26eedc0c5755fd715cd7242c0244cc5319c3bb13e93e0d2be4563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19016746&rfr_iscdi=true |